INVESTORS
Morningside Venture Capital ("Morningside") is one of
China's earliest early-stage venture investors with over US$ 1.5 billion under management,
from the commitment of sovereign wealth funds,family offices, funds of funds, university
endowment and other major investors. With a team that has worked together for almost 20
years, Morningside continues to discover, support and encourage entrepreneurs.
Loyal Valley Capital (LVC) is a thematic, research-driven
private equity firm focused on deep fundamental research and unlocking value through
post-investment value-creation. LVC manages capital on behalf of a geographically
diversified group of long-term institutional investors, including sovereign wealth funds,
private banks, family offices, and fund of funds managers, from across the Americas, Europe,
and Asia.
Founded in 2015, Apricot Capital focuses on investment in
innovative companies in life science industry. Apricot team has strong industry experience
and deep insight in healthcare sectors and is quickly emerging as a leading biotech investor
in China.
Oceanpine Capital is an institutional growth equity
investment company formed by seasoned entrepreneurs and sophisticated investors with 20
years of in-depth industry operational and business building experiences in both China and
the US. With a perspective of achieving successful growth over the long term, Oceanpine
partners visionary entrepreneurs to build world-class companies together over a period of
years rather than on the short-term impact.